Evidence map›Paper›PMID 37970380›Full record

ReviewFood science & nutrition2023

Exploration of nutritional, pharmacological, and the processing trends for valorization of finger millet (

Rhythm Kalsi, Jasleen Bhasin, Gulden Goksen, Piyush Kashyap

Open access · hybridAbstract readReview
In one paragraph

Review in Food science & nutrition, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 22 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Rhythm KalsiDepartment of Food Technology and Nutrition, School of Agriculture Lovely Professional University Phagwara Punjab India.
Jasleen BhasinDepartment of Food Technology and Nutrition, School of Agriculture Lovely Professional University Phagwara Punjab India.
Gulden GoksenDepartment of Food Technology Vocational School of Technical Sciences at Mersin Tarsus Organized Industrial Zone, Tarsus University Mersin Turkey.ORCID https://orcid.org/0000-0002-5432-7936
Piyush KashyapDepartment of Food Technology and Nutrition, School of Agriculture Lovely Professional University Phagwara Punjab India.
Lovely Professional University · INTarsus University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

High nutrient variability and food security are the needs of the hour. Millets may be as effective as other cereal crops for dealing with severe malnutrition and increasing global population problems. Due to their physiologically active components, millets have attracted more research interest. Finger millet (FM), one of the climate-resilient and minor cereal crop species, is well known for several health benefits, primarily attributed to its nutritional value and polyphenolic content. FM seed coat phenolics exhibit excellent anti-diabetic, anti-oxidant, antimicrobial, anti-osteoporosis, wound healing, anti-lithiatic, inhibiting collagen glycation, cross-linking, and enzyme properties, which may serve well for the pharmacological purposes. Furthermore, the processing of FM is an important factor in its commercial use. It is necessary to invent some novel technologies to increase the productivity of FM by lowering the cost of processing and its effective utilization in the pharmaceutical and food industries. The literature presented will further explore the potential prospects of processing as well as value-added utilization and its nutritional and pharmacological aspects in view of initiating further research in the food industry to formulate ready-to-eat and ready-to-cook products, thereby acting as future crops for sustainability.

Indexed as

finger milletsnutritionalpharmacologicalphytochemicalprocessingutilization

Identifiers

PMID37970380
PMCPMC10630810
OpenAlexW4386572814

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.